Inhibition of the miR-155 and protein prenylation feedback loop alleviated acute graft-versus-host disease through regulating the balance between T helper 17 and Treg cells

MicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte differentiation, however the mechanism remains elusive. In this study, we found that the expression of miR-155 and protein prenyltransferases in...

Full description

Saved in:
Bibliographic Details
Published inTransplant immunology Vol. 69; p. 101461
Main Authors Wang, Xiaoxiao, Zhang, Ran, Huang, Zhenli, Zang, Sibin, Wu, Qiuling, Xia, Linghui
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.12.2021
Subjects
Online AccessGet full text
ISSN0966-3274
1878-5492
1878-5492
DOI10.1016/j.trim.2021.101461

Cover

Loading…
Abstract MicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte differentiation, however the mechanism remains elusive. In this study, we found that the expression of miR-155 and protein prenyltransferases in peripheral blood T lymphocytes of aGVHD mice was significantly increased. Suppression of miR-155 by antagomir-155 could remarkably reduce prenyltransferases mRNA and protein expression in T lymphocytes of aGVHD mice. Conversely, prenyltransferase inhibitors significantly reduced the level of miR-155. Inhibition of this feedback loop of miR-155 and protein prenylation in aGVHD mice led to improved survival and lower aGVHD histopathology scores and significantly induced T cell deficient differentiation towards T helper 17 (Th17) cells and titled differentiation towards CD4+CD25hi regulatory T (Treg) cells. Furthermore, the immunoregulatory effects and protection from aGVHD of prenyltransferase inhibitors could be reversed by the addition of miR-155. The dual treatment of prenylation inhibitors and antagomir-155 showed synergistic effects on T polarization and protection from aGVHD. Consistent with the in vivo changes, inhibition of this feedback loop of miR-155 and protein prenylation affected Th17 and Treg cell polarization in vitro. Our data suggest that miR-155 and protein prenylation may constitute a feedback loop that amplifies immune and inflammatory responses in subjects with aGVHD, and they may serve as potential targets for aGVHD prophylaxis and treatment. •MiR-155 and prenyltransferase formed a feedback loop in human T lymphocytes.•Inhibition of the feedback loop between miR-155/protein prenylation affected Th17 and Treg cell polarization in vitro.•MiR-155 levels and protein prenylation were increased and interacted in aGVHD mice.•Suppression of miR-155 or protein prenylation in T lymphocytes alleviated murine aGVHD.•Interventions targeting the miR-155/protein prenylation feedback loop affected Th17 and Treg cell polarization in aGVHD mice.
AbstractList AbstractMicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte differentiation, however the mechanism remains elusive. In this study, we found that the expression of miR-155 and protein prenyltransferases in peripheral blood T lymphocytes of aGVHD mice was significantly increased. Suppression of miR-155 by antagomir-155 could remarkably reduce prenyltransferases mRNA and protein expression in T lymphocytes of aGVHD mice. Conversely, prenyltransferase inhibitors significantly reduced the level of miR-155. Inhibition of this feedback loop of miR-155 and protein prenylation in aGVHD mice led to improved survival and lower aGVHD histopathology scores and significantly induced T cell deficient differentiation towards T helper 17 (Th17) cells and titled differentiation towards CD4 +CD25 hi regulatory T (Treg) cells. Furthermore, the immunoregulatory effects and protection from aGVHD of prenyltransferase inhibitors could be reversed by the addition of miR-155. The dual treatment of prenylation inhibitors and antagomir-155 showed synergistic effects on T polarization and protection from aGVHD. Consistent with the in vivo changes, inhibition of this feedback loop of miR-155 and protein prenylation affected Th17 and Treg cell polarization in vitro. Our data suggest that miR-155 and protein prenylation may constitute a feedback loop that amplifies immune and inflammatory responses in subjects with aGVHD, and they may serve as potential targets for aGVHD prophylaxis and treatment.
MicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte differentiation, however the mechanism remains elusive. In this study, we found that the expression of miR-155 and protein prenyltransferases in peripheral blood T lymphocytes of aGVHD mice was significantly increased. Suppression of miR-155 by antagomir-155 could remarkably reduce prenyltransferases mRNA and protein expression in T lymphocytes of aGVHD mice. Conversely, prenyltransferase inhibitors significantly reduced the level of miR-155. Inhibition of this feedback loop of miR-155 and protein prenylation in aGVHD mice led to improved survival and lower aGVHD histopathology scores and significantly induced T cell deficient differentiation towards T helper 17 (Th17) cells and titled differentiation towards CD4+CD25hi regulatory T (Treg) cells. Furthermore, the immunoregulatory effects and protection from aGVHD of prenyltransferase inhibitors could be reversed by the addition of miR-155. The dual treatment of prenylation inhibitors and antagomir-155 showed synergistic effects on T polarization and protection from aGVHD. Consistent with the in vivo changes, inhibition of this feedback loop of miR-155 and protein prenylation affected Th17 and Treg cell polarization in vitro. Our data suggest that miR-155 and protein prenylation may constitute a feedback loop that amplifies immune and inflammatory responses in subjects with aGVHD, and they may serve as potential targets for aGVHD prophylaxis and treatment.MicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte differentiation, however the mechanism remains elusive. In this study, we found that the expression of miR-155 and protein prenyltransferases in peripheral blood T lymphocytes of aGVHD mice was significantly increased. Suppression of miR-155 by antagomir-155 could remarkably reduce prenyltransferases mRNA and protein expression in T lymphocytes of aGVHD mice. Conversely, prenyltransferase inhibitors significantly reduced the level of miR-155. Inhibition of this feedback loop of miR-155 and protein prenylation in aGVHD mice led to improved survival and lower aGVHD histopathology scores and significantly induced T cell deficient differentiation towards T helper 17 (Th17) cells and titled differentiation towards CD4+CD25hi regulatory T (Treg) cells. Furthermore, the immunoregulatory effects and protection from aGVHD of prenyltransferase inhibitors could be reversed by the addition of miR-155. The dual treatment of prenylation inhibitors and antagomir-155 showed synergistic effects on T polarization and protection from aGVHD. Consistent with the in vivo changes, inhibition of this feedback loop of miR-155 and protein prenylation affected Th17 and Treg cell polarization in vitro. Our data suggest that miR-155 and protein prenylation may constitute a feedback loop that amplifies immune and inflammatory responses in subjects with aGVHD, and they may serve as potential targets for aGVHD prophylaxis and treatment.
MicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte differentiation, however the mechanism remains elusive. In this study, we found that the expression of miR-155 and protein prenyltransferases in peripheral blood T lymphocytes of aGVHD mice was significantly increased. Suppression of miR-155 by antagomir-155 could remarkably reduce prenyltransferases mRNA and protein expression in T lymphocytes of aGVHD mice. Conversely, prenyltransferase inhibitors significantly reduced the level of miR-155. Inhibition of this feedback loop of miR-155 and protein prenylation in aGVHD mice led to improved survival and lower aGVHD histopathology scores and significantly induced T cell deficient differentiation towards T helper 17 (Th17) cells and titled differentiation towards CD4+CD25hi regulatory T (Treg) cells. Furthermore, the immunoregulatory effects and protection from aGVHD of prenyltransferase inhibitors could be reversed by the addition of miR-155. The dual treatment of prenylation inhibitors and antagomir-155 showed synergistic effects on T polarization and protection from aGVHD. Consistent with the in vivo changes, inhibition of this feedback loop of miR-155 and protein prenylation affected Th17 and Treg cell polarization in vitro. Our data suggest that miR-155 and protein prenylation may constitute a feedback loop that amplifies immune and inflammatory responses in subjects with aGVHD, and they may serve as potential targets for aGVHD prophylaxis and treatment. •MiR-155 and prenyltransferase formed a feedback loop in human T lymphocytes.•Inhibition of the feedback loop between miR-155/protein prenylation affected Th17 and Treg cell polarization in vitro.•MiR-155 levels and protein prenylation were increased and interacted in aGVHD mice.•Suppression of miR-155 or protein prenylation in T lymphocytes alleviated murine aGVHD.•Interventions targeting the miR-155/protein prenylation feedback loop affected Th17 and Treg cell polarization in aGVHD mice.
MicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte differentiation, however the mechanism remains elusive. In this study, we found that the expression of miR-155 and protein prenyltransferases in peripheral blood T lymphocytes of aGVHD mice was significantly increased. Suppression of miR-155 by antagomir-155 could remarkably reduce prenyltransferases mRNA and protein expression in T lymphocytes of aGVHD mice. Conversely, prenyltransferase inhibitors significantly reduced the level of miR-155. Inhibition of this feedback loop of miR-155 and protein prenylation in aGVHD mice led to improved survival and lower aGVHD histopathology scores and significantly induced T cell deficient differentiation towards T helper 17 (Th17) cells and titled differentiation towards CD4 CD25 regulatory T (Treg) cells. Furthermore, the immunoregulatory effects and protection from aGVHD of prenyltransferase inhibitors could be reversed by the addition of miR-155. The dual treatment of prenylation inhibitors and antagomir-155 showed synergistic effects on T polarization and protection from aGVHD. Consistent with the in vivo changes, inhibition of this feedback loop of miR-155 and protein prenylation affected Th17 and Treg cell polarization in vitro. Our data suggest that miR-155 and protein prenylation may constitute a feedback loop that amplifies immune and inflammatory responses in subjects with aGVHD, and they may serve as potential targets for aGVHD prophylaxis and treatment.
ArticleNumber 101461
Author Zhang, Ran
Wu, Qiuling
Huang, Zhenli
Xia, Linghui
Zang, Sibin
Wang, Xiaoxiao
Author_xml – sequence: 1
  givenname: Xiaoxiao
  surname: Wang
  fullname: Wang, Xiaoxiao
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 JieFang Avenue,Wuhan 430022, China
– sequence: 2
  givenname: Ran
  surname: Zhang
  fullname: Zhang, Ran
  organization: Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China
– sequence: 3
  givenname: Zhenli
  surname: Huang
  fullname: Huang, Zhenli
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 JieFang Avenue,Wuhan 430022, China
– sequence: 4
  givenname: Sibin
  surname: Zang
  fullname: Zang, Sibin
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 JieFang Avenue,Wuhan 430022, China
– sequence: 5
  givenname: Qiuling
  surname: Wu
  fullname: Wu, Qiuling
  email: 1999XH0535@hust.edu.cn
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 JieFang Avenue,Wuhan 430022, China
– sequence: 6
  givenname: Linghui
  surname: Xia
  fullname: Xia, Linghui
  email: linghuixia@hust.edu.cn
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 JieFang Avenue,Wuhan 430022, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34487810$$D View this record in MEDLINE/PubMed
BookMark eNqFkl1vFCEYhYmpsdvqH_DCcOnNrMB8MGOMSdP40aSJia7XhIF3dtiysAKzZv-TP1Jmt3rRxMrNm5DnHOAcLtCZ8w4QeknJkhLavNksUzDbJSOMzhtVQ5-gBW15W9RVx87QgnRNU5SMV-foIsYNIYTVHX-GzsuqyhglC_Trxo2mN8l4h_2A0wh4a74WtK6xdBrvgk9gXJ7gDlYesQFA91LdYev9DktrYW9kAo2lmhLgdZBDKvYQ4hSL0ceEtYkgI2Tz4Kf1iAOsp9nLrY_n9dJKp_KE9BPA4RUewe4gYMqPd1hlHiuwNj5HTwdpI7y4n5fo-8cPq-vPxe2XTzfXV7eFqhqWim7oalr1HbBmaGqpVNNxXZMeSMOlHhjVNeesbStaAeugLUmTIQbtACXXmpeX6PXJNz__xwQxia2J8w2kAz9FwWpOaF4lzeire3Tqt6DFLjciw0H8STgD7ASo4GMMMPxFKBFzjWIj5hrFXKM41ZhF7QORMumYfgrS2Mel705SyAHtDQQRlYGcrzYBVBLam8fl7x_IlTXOKGnv4ABx46fgcvSCisgEEd_mLzb_MEYJyRZ1Nnj7b4P_nf4b0r_ibA
CitedBy_id crossref_primary_10_4110_in_2025_25_e11
crossref_primary_10_1007_s00011_022_01643_6
crossref_primary_10_1016_j_genrep_2024_102037
Cites_doi 10.1371/journal.ppat.1003222
10.1182/blood-2008-08-172155
10.1111/1755-5922.12282
10.1080/08830180903093796
10.1111/imm.12468
10.1182/blood-2014-07-586511
10.4048/jbc.2018.21.2.112
10.1038/nrc3151
10.1182/blood-2011-10-387522
10.1126/science.1139253
10.1016/j.cytogfr.2011.05.002
10.1128/MCB.06597-11
10.1182/blood-2011-03-340315
10.1016/S0140-6736(09)60237-3
10.1016/S1083-8791(03)00087-9
10.1056/NEJMra1609337
10.1182/blood-2011-02-334904
10.1016/j.cell.2012.04.005
10.1182/blood-2007-08-106005
10.1182/blood-2013-06-510586
10.18632/oncotarget.15579
10.1182/blood-2008-06-162420
10.1371/journal.ppat.1006790
10.3324/haematol.2012.065789
10.1016/j.cell.2008.12.027
10.1126/scisignal.2005970
10.1182/blood-2014-12-617258
10.1186/s12943-014-0284-y
10.1038/nchembio834
10.1128/MCB.00941-08
10.1101/gad.209619.112
10.1038/nrd2221
10.1016/j.coph.2012.06.013
10.1016/j.atherosclerosis.2007.07.031
10.1016/j.cell.2004.12.035
10.1038/nature01158
10.1146/annurev.bi.65.070196.001325
ContentType Journal Article
Copyright 2021 Elsevier B.V.
Elsevier B.V.
Copyright © 2021 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2021 Elsevier B.V.
– notice: Elsevier B.V.
– notice: Copyright © 2021 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.trim.2021.101461
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1878-5492
EndPage 101461
ExternalDocumentID 34487810
10_1016_j_trim_2021_101461
S0966327421001015
1_s2_0_S0966327421001015
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29Q
36B
4.4
457
4G.
53G
5VS
7-5
71M
8P~
9JM
AAAJQ
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFRF
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
CJTIS
CNWQP
COF
CS3
DU5
EBS
EBX
EFJIC
EFKBS
EJD
EMOBN
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDU
HMG
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
LUGTX
M29
M41
MO0
N9A
O-L
O9-
O9~
OAUVE
OK0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SDF
SDG
SES
SEW
SIN
SPCBC
SSH
SSI
SSZ
T5K
UHS
UNMZH
WUQ
Z5R
~G-
AFCTW
AGRNS
RIG
AACTN
AAIAV
ABDBF
ABLVK
ABYKQ
AFKWA
AJBFU
AJOXV
AMFUW
EAD
EAP
EAS
EFLBG
EHN
EMB
EMK
EPT
ESX
LCYCR
SV3
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c462t-9f9514b9e26f65acc697d50be067adf21d577288414e29e8306acc2e8fe37dd73
IEDL.DBID .~1
ISSN 0966-3274
1878-5492
IngestDate Fri Jul 11 04:44:24 EDT 2025
Thu Apr 03 07:01:59 EDT 2025
Tue Jul 01 04:18:49 EDT 2025
Thu Apr 24 23:01:03 EDT 2025
Fri Feb 23 02:43:16 EST 2024
Wed Jun 18 06:48:29 EDT 2025
Tue Aug 26 17:03:02 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords microRNA-155
Acute graft-versus-host disease
Polarization
T lymphocyte
Protein prenylation
Language English
License Copyright © 2021 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-9f9514b9e26f65acc697d50be067adf21d577288414e29e8306acc2e8fe37dd73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 34487810
PQID 2570111131
PQPubID 23479
PageCount 1
ParticipantIDs proquest_miscellaneous_2570111131
pubmed_primary_34487810
crossref_primary_10_1016_j_trim_2021_101461
crossref_citationtrail_10_1016_j_trim_2021_101461
elsevier_sciencedirect_doi_10_1016_j_trim_2021_101461
elsevier_clinicalkeyesjournals_1_s2_0_S0966327421001015
elsevier_clinicalkey_doi_10_1016_j_trim_2021_101461
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-12-01
PublicationDateYYYYMMDD 2021-12-01
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Transplant immunology
PublicationTitleAlternate Transpl Immunol
PublicationYear 2021
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Testa, Pelosi, Castelli, Labbaye (bb0115) 2017; 3
Mashima (bb0120) 2015; 145
Ranganathan, Heaphy, Costinean, Stauffer, Na, Hamadani, Santhanam, Mao, Taylor, Sandhu, He, Shana’ah, Nuovo, Lagana, Cascione, Obad, Broom, Kauppinen, Byrd, Caligiuri, Perrotti, Hadley, Marcucci, Devine, Blazar, Croce, Garzon (bb0105) 2012; 119
Jing, Guo, Bao, Li, Lin, Lu, Wang (bb0215) 2017; 35
Youssef, Stuve, Patarroyo, Ruiz, Radosevich, Hur, Bravo, Mitchell, Sobel, Steinman, Zamvil (bb0205) 2002; 420
Kappel, Goldberg, King, Suh, Smith, Ligh, Holland, Grubin, Mark, Liu, Iwakura, Heller, van den Brink (bb0175) 2009; 113
Liu, Wang, Saijilafu, Zhang, Zhou (bb0160) 2013; 27
Zhang, Casey (bb0060) 1996; 65
Mausner-Fainberg, Luboshits, Mor, Maysel-Auslender, Rubinstein, Keren, George (bb0210) 2008; 197
Leng, Pan, Qin, Chen, Ye (bb0030) 2011; 22
Carlson, West, Coghill, Panoskaltsis-Mortari, Blazar, Serody (bb0170) 2009; 113
Jury, Isenberg, Mauri, Ehrenstein (bb0075) 2006; 177
Etna, Sinigaglia, Grassi, Giacomini, Romagnoli, Pardini, Severa, Cruciani, Rizzo, Anastasiadou, Di Camillo, Barzon, Fimia, Manganelli, Coccia (bb0125) 2018; 14
Zitzer, Snyder, Meng, Taylor, Efebera, Devine, Blazar, Garzon, Ranganathan (bb0100) 2018; 200
Zeiser, Blazar (bb0010) 2017; 377
Konstantinopoulos, Karamouzis, Papavassiliou (bb0055) 2007; 6
Hechinger, Maas, Durr, Leonhardt, Prinz, Marks, Gerlach, Hofmann, Fisch, Finke, Pircher, Zeiser (bb0080) 2013; 98
Marsolier, Pineau, Medjkane, Perichon, Yin, Flemington, Weitzman, Weitzman (bb0165) 2013; 9
Holstein, Hohl (bb0195) 2012; 12
Ghorpade, Leyland, Kurowska-Stolarska, Patil, Balaji (bb0130) 2012; 32
Ebert, Sharp (bb0155) 2012; 149
Berg, Rusch, Vartak, Jungst, Schauss, Waldmann, Hedberg, Pallasch, Bastiaens, Hallek, Wendtner, Frenzel (bb0135) 2015; 125
Xiao, Wang, Li, Baker, Guo, Corbet, Tsalik, Li, Palmer, Woods, Li, Chao, He (bb0035) 2013; 122
Ferrara, Levine, Reddy, Holler (bb0005) 2009; 373
Yu, Wang, Liu, Kaosaard, Semple, Anasetti, Yu (bb0180) 2011; 118
Zeiser, Youssef, Baker, Kambham, Steinman, Negrin (bb0200) 2007; 110
Zhang R, Wang X, Hong M, Luo T, Zhao M, Shen H, Fang J, Li X, Zang S, Chen P, Nie D, Zheng P, Wu Q, Xia L (2017) Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Oncotarget 8 (14):23360-23375. Doi
Chen, Smith, Iype, Prestipino, Pfeifer, Grundmann, Schmitt-Graeff, Idzko, Beck, Prinz, Finke, Duyster, Zeiser (bb0045) 2015; 126
Na, Lee, Kang, Cho, Nam, Kim, Ha, Chung, Lee, Kwon, Koh, Kim (bb0070) 2004; 173
Thurnher, Gruenbacher (bb0065) 2015; 8
Zhao, He, Yang, Luo, Liu (bb0145) 2018; 21
Witzig, Tang, Micallef, Ansell, Link, Inwards, Porrata, Johnston, Colgan, Markovic, Nowakowski, Thompson, Allmer, Maurer, Gupta, Weiner, Hohl, Kurtin, Ding, Loegering, Schneider, Peterson, Habermann, Kaufmann (bb0190) 2011; 118
Resh (bb0050) 2006; 2
.
Lewis, Burge, Bartel (bb0110) 2005; 120
Rodriguez, Vigorito, Clare, Warren, Couttet, Soond, van Dongen, Grocock, Das, Miska, Vetrie, Okkenhaug, Enright, Dougan, Turner, Bradley (bb0025) 2007; 316
Koumangoye, Andl, Taubenslag, Zilberman, Taylor, Loomans, Andl (bb0150) 2015; 14
Krenger, Snyder, Byon, Falzarano, Ferrara (bb0085) 1995; 155
Xiao, Rajewsky (bb0015) 2009; 136
Kaplan, Anderson, McNiff, Jain, Shlomchik, Shlomchik (bb0090) 2004; 173
Tili, Croce, Michaille (bb0020) 2009; 28
Berndt, Hamilton, Sebti (bb0185) 2011; 11
Korngold, Marini, de Baca, Murphy, Giles-Komar (bb0095) 2003; 9
Kong, Yang, He, Zhao, Coppola, Dalton, Cheng (bb0140) 2008; 28
10.1016/j.trim.2021.101461_bb0040
Na (10.1016/j.trim.2021.101461_bb0070) 2004; 173
Kong (10.1016/j.trim.2021.101461_bb0140) 2008; 28
Zhao (10.1016/j.trim.2021.101461_bb0145) 2018; 21
Ebert (10.1016/j.trim.2021.101461_bb0155) 2012; 149
Marsolier (10.1016/j.trim.2021.101461_bb0165) 2013; 9
Rodriguez (10.1016/j.trim.2021.101461_bb0025) 2007; 316
Leng (10.1016/j.trim.2021.101461_bb0030) 2011; 22
Jury (10.1016/j.trim.2021.101461_bb0075) 2006; 177
Berg (10.1016/j.trim.2021.101461_bb0135) 2015; 125
Zeiser (10.1016/j.trim.2021.101461_bb0010) 2017; 377
Xiao (10.1016/j.trim.2021.101461_bb0015) 2009; 136
Holstein (10.1016/j.trim.2021.101461_bb0195) 2012; 12
Liu (10.1016/j.trim.2021.101461_bb0160) 2013; 27
Carlson (10.1016/j.trim.2021.101461_bb0170) 2009; 113
Testa (10.1016/j.trim.2021.101461_bb0115) 2017; 3
Chen (10.1016/j.trim.2021.101461_bb0045) 2015; 126
Ranganathan (10.1016/j.trim.2021.101461_bb0105) 2012; 119
Hechinger (10.1016/j.trim.2021.101461_bb0080) 2013; 98
Krenger (10.1016/j.trim.2021.101461_bb0085) 1995; 155
Zeiser (10.1016/j.trim.2021.101461_bb0200) 2007; 110
Resh (10.1016/j.trim.2021.101461_bb0050) 2006; 2
Mausner-Fainberg (10.1016/j.trim.2021.101461_bb0210) 2008; 197
Ferrara (10.1016/j.trim.2021.101461_bb0005) 2009; 373
Jing (10.1016/j.trim.2021.101461_bb0215) 2017; 35
Mashima (10.1016/j.trim.2021.101461_bb0120) 2015; 145
Berndt (10.1016/j.trim.2021.101461_bb0185) 2011; 11
Youssef (10.1016/j.trim.2021.101461_bb0205) 2002; 420
Konstantinopoulos (10.1016/j.trim.2021.101461_bb0055) 2007; 6
Etna (10.1016/j.trim.2021.101461_bb0125) 2018; 14
Kaplan (10.1016/j.trim.2021.101461_bb0090) 2004; 173
Zitzer (10.1016/j.trim.2021.101461_bb0100) 2018; 200
Xiao (10.1016/j.trim.2021.101461_bb0035) 2013; 122
Tili (10.1016/j.trim.2021.101461_bb0020) 2009; 28
Thurnher (10.1016/j.trim.2021.101461_bb0065) 2015; 8
Yu (10.1016/j.trim.2021.101461_bb0180) 2011; 118
Korngold (10.1016/j.trim.2021.101461_bb0095) 2003; 9
Koumangoye (10.1016/j.trim.2021.101461_bb0150) 2015; 14
Kappel (10.1016/j.trim.2021.101461_bb0175) 2009; 113
Witzig (10.1016/j.trim.2021.101461_bb0190) 2011; 118
Lewis (10.1016/j.trim.2021.101461_bb0110) 2005; 120
Ghorpade (10.1016/j.trim.2021.101461_bb0130) 2012; 32
Zhang (10.1016/j.trim.2021.101461_bb0060) 1996; 65
References_xml – volume: 27
  start-page: 1473
  year: 2013
  end-page: 1483
  ident: bb0160
  article-title: MicroRNA-138 and SIRT1 form a mutual negative feedback loop to regulate mammalian axon regeneration
  publication-title: Genes Dev.
– volume: 125
  start-page: 2948
  year: 2015
  end-page: 2957
  ident: bb0135
  article-title: miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL
  publication-title: Blood
– reference: Zhang R, Wang X, Hong M, Luo T, Zhao M, Shen H, Fang J, Li X, Zang S, Chen P, Nie D, Zheng P, Wu Q, Xia L (2017) Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Oncotarget 8 (14):23360-23375. Doi:
– volume: 65
  start-page: 241
  year: 1996
  end-page: 269
  ident: bb0060
  article-title: Protein prenylation: molecular mechanisms and functional consequences
  publication-title: Annu. Rev. Biochem.
– volume: 8
  year: 2015
  ident: bb0065
  article-title: T lymphocyte regulation by mevalonate metabolism
  publication-title: Sci. Signal.
– volume: 126
  start-page: 103
  year: 2015
  end-page: 112
  ident: bb0045
  article-title: MicroRNA-155-deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation
  publication-title: Blood
– volume: 155
  start-page: 585
  year: 1995
  end-page: 593
  ident: bb0085
  article-title: Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease
  publication-title: J. Immunol. (Baltimore, Md : 1950)
– volume: 118
  start-page: 4882
  year: 2011
  end-page: 4889
  ident: bb0190
  article-title: Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas
  publication-title: Blood
– volume: 316
  start-page: 608
  year: 2007
  end-page: 611
  ident: bb0025
  article-title: Requirement of bic/microRNA-155 for normal immune function
  publication-title: Science (New York, N.Y.)
– volume: 118
  start-page: 5011
  year: 2011
  end-page: 5020
  ident: bb0180
  article-title: Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORgammat in mice
  publication-title: Blood
– volume: 6
  start-page: 541
  year: 2007
  end-page: 555
  ident: bb0055
  article-title: Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets
  publication-title: Nat. Rev. Drug Discov.
– volume: 200
  start-page: 4170
  year: 2018
  end-page: 4179
  ident: bb0100
  article-title: MicroRNA-155 modulates acute graft-versus-host disease by impacting T cell expansion, migration, and effector function
  publication-title: J. Immunol. (Baltimore, Md : 1950)
– volume: 122
  start-page: 3365
  year: 2013
  end-page: 3375
  ident: bb0035
  article-title: Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease
  publication-title: Blood
– volume: 22
  start-page: 141
  year: 2011
  end-page: 147
  ident: bb0030
  article-title: Role of microRNA-155 in autoimmunity
  publication-title: Cytokine Growth Factor Rev.
– volume: 32
  start-page: 2239
  year: 2012
  end-page: 2253
  ident: bb0130
  article-title: MicroRNA-155 is required for Mycobacterium bovis BCG-mediated apoptosis of macrophages
  publication-title: Mol. Cell. Biol.
– volume: 21
  start-page: 112
  year: 2018
  end-page: 123
  ident: bb0145
  article-title: Histone Deacetylase-3 modification of MicroRNA-31 promotes cell proliferation and aerobic glycolysis in breast Cancer and is predictive of poor prognosis
  publication-title: J. Breast Cancer
– volume: 119
  start-page: 4786
  year: 2012
  end-page: 4797
  ident: bb0105
  article-title: Regulation of acute graft-versus-host disease by microRNA-155
  publication-title: Blood
– volume: 3
  year: 2017
  ident: bb0115
  article-title: miR-146 and miR-155: two key modulators of immune response and tumor development. Non-coding
  publication-title: RNA
– volume: 2
  start-page: 584
  year: 2006
  end-page: 590
  ident: bb0050
  article-title: Trafficking and signaling by fatty-acylated and prenylated proteins
  publication-title: Nat. Chem. Biol.
– volume: 110
  start-page: 4588
  year: 2007
  end-page: 4598
  ident: bb0200
  article-title: Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity
  publication-title: Blood
– volume: 14
  year: 2018
  ident: bb0125
  article-title: Mycobacterium tuberculosis-induced miR-155 subverts autophagy by targeting ATG3 in human dendritic cells
  publication-title: PLoS Pathog.
– volume: 173
  start-page: 5467
  year: 2004
  end-page: 5475
  ident: bb0090
  article-title: Target antigens determine graft-versus-host disease phenotype
  publication-title: J. Immunol. (Baltimore, Md : 1950)
– volume: 113
  start-page: 1365
  year: 2009
  end-page: 1374
  ident: bb0170
  article-title: In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations
  publication-title: Blood
– volume: 12
  start-page: 704
  year: 2012
  end-page: 709
  ident: bb0195
  article-title: Is there a future for prenyltransferase inhibitors in cancer therapy?
  publication-title: Curr. Opin. Pharmacol.
– volume: 377
  start-page: 2167
  year: 2017
  end-page: 2179
  ident: bb0010
  article-title: Acute graft-versus-host disease - biologic process, prevention, and therapy
  publication-title: N. Engl. J. Med.
– volume: 98
  start-page: 31
  year: 2013
  end-page: 40
  ident: bb0080
  article-title: Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells
  publication-title: Haematologica
– volume: 420
  start-page: 78
  year: 2002
  end-page: 84
  ident: bb0205
  article-title: The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
  publication-title: Nature
– volume: 28
  start-page: 264
  year: 2009
  end-page: 284
  ident: bb0020
  article-title: miR-155: on the crosstalk between inflammation and cancer
  publication-title: Int. Rev. Immunol.
– volume: 197
  start-page: 829
  year: 2008
  end-page: 839
  ident: bb0210
  article-title: The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells
  publication-title: Atherosclerosis
– volume: 177
  start-page: 7416
  year: 2006
  end-page: 7422
  ident: bb0075
  article-title: Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus
  publication-title: J. Immunol. (Baltimore, Md : 1950)
– volume: 373
  start-page: 1550
  year: 2009
  end-page: 1561
  ident: bb0005
  article-title: Graft-versus-host disease
  publication-title: Lancet (London, England)
– volume: 145
  start-page: 323
  year: 2015
  end-page: 333
  ident: bb0120
  article-title: Physiological roles of miR-155
  publication-title: Immunology
– volume: 14
  start-page: 24
  year: 2015
  ident: bb0150
  article-title: SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells
  publication-title: Mol. Cancer
– volume: 9
  start-page: 292
  year: 2003
  end-page: 303
  ident: bb0095
  article-title: Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses
  publication-title: Biology of blood and marrow transplantation
– volume: 11
  start-page: 775
  year: 2011
  end-page: 791
  ident: bb0185
  article-title: Targeting protein prenylation for cancer therapy
  publication-title: Nat. Rev. Cancer
– reference: .
– volume: 136
  start-page: 26
  year: 2009
  end-page: 36
  ident: bb0015
  article-title: MicroRNA control in the immune system: basic principles
  publication-title: Cell
– volume: 113
  start-page: 945
  year: 2009
  end-page: 952
  ident: bb0175
  article-title: IL-17 contributes to CD4-mediated graft-versus-host disease
  publication-title: Blood
– volume: 120
  start-page: 15
  year: 2005
  end-page: 20
  ident: bb0110
  article-title: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
  publication-title: Cell
– volume: 35
  year: 2017
  ident: bb0215
  article-title: Pitavastatin up-regulates eNOS production by suppressing miR-155 expression in lipopolysaccharide-stimulated human umbilical vein endothelial cells
  publication-title: Cardiovasc. Ther.
– volume: 173
  start-page: 1276
  year: 2004
  end-page: 1283
  ident: bb0070
  article-title: Inhibition of farnesyltransferase prevents collagen-induced arthritis by down-regulation of inflammatory gene expression through suppression of p21(ras)-dependent NF-kappaB activation
  publication-title: J. Immunol. (Baltimore, Md : 1950)
– volume: 9
  year: 2013
  ident: bb0165
  article-title: OncomiR addiction is generated by a miR-155 feedback loop in Theileria-transformed leukocytes
  publication-title: PLoS Pathog.
– volume: 28
  start-page: 6773
  year: 2008
  end-page: 6784
  ident: bb0140
  article-title: MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA
  publication-title: Mol. Cell. Biol.
– volume: 149
  start-page: 515
  year: 2012
  end-page: 524
  ident: bb0155
  article-title: Roles for microRNAs in conferring robustness to biological processes
  publication-title: Cell
– volume: 9
  issue: 4
  year: 2013
  ident: 10.1016/j.trim.2021.101461_bb0165
  article-title: OncomiR addiction is generated by a miR-155 feedback loop in Theileria-transformed leukocytes
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1003222
– volume: 113
  start-page: 945
  issue: 4
  year: 2009
  ident: 10.1016/j.trim.2021.101461_bb0175
  article-title: IL-17 contributes to CD4-mediated graft-versus-host disease
  publication-title: Blood
  doi: 10.1182/blood-2008-08-172155
– volume: 35
  issue: 5
  year: 2017
  ident: 10.1016/j.trim.2021.101461_bb0215
  article-title: Pitavastatin up-regulates eNOS production by suppressing miR-155 expression in lipopolysaccharide-stimulated human umbilical vein endothelial cells
  publication-title: Cardiovasc. Ther.
  doi: 10.1111/1755-5922.12282
– volume: 28
  start-page: 264
  issue: 5
  year: 2009
  ident: 10.1016/j.trim.2021.101461_bb0020
  article-title: miR-155: on the crosstalk between inflammation and cancer
  publication-title: Int. Rev. Immunol.
  doi: 10.1080/08830180903093796
– volume: 145
  start-page: 323
  issue: 3
  year: 2015
  ident: 10.1016/j.trim.2021.101461_bb0120
  article-title: Physiological roles of miR-155
  publication-title: Immunology
  doi: 10.1111/imm.12468
– volume: 125
  start-page: 2948
  issue: 19
  year: 2015
  ident: 10.1016/j.trim.2021.101461_bb0135
  article-title: miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL
  publication-title: Blood
  doi: 10.1182/blood-2014-07-586511
– volume: 21
  start-page: 112
  issue: 2
  year: 2018
  ident: 10.1016/j.trim.2021.101461_bb0145
  article-title: Histone Deacetylase-3 modification of MicroRNA-31 promotes cell proliferation and aerobic glycolysis in breast Cancer and is predictive of poor prognosis
  publication-title: J. Breast Cancer
  doi: 10.4048/jbc.2018.21.2.112
– volume: 11
  start-page: 775
  issue: 11
  year: 2011
  ident: 10.1016/j.trim.2021.101461_bb0185
  article-title: Targeting protein prenylation for cancer therapy
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3151
– volume: 119
  start-page: 4786
  issue: 20
  year: 2012
  ident: 10.1016/j.trim.2021.101461_bb0105
  article-title: Regulation of acute graft-versus-host disease by microRNA-155
  publication-title: Blood
  doi: 10.1182/blood-2011-10-387522
– volume: 316
  start-page: 608
  issue: 5824
  year: 2007
  ident: 10.1016/j.trim.2021.101461_bb0025
  article-title: Requirement of bic/microRNA-155 for normal immune function
  publication-title: Science (New York, N.Y.)
  doi: 10.1126/science.1139253
– volume: 177
  start-page: 7416
  issue: 10
  year: 2006
  ident: 10.1016/j.trim.2021.101461_bb0075
  article-title: Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus
  publication-title: J. Immunol. (Baltimore, Md : 1950)
– volume: 22
  start-page: 141
  issue: 3
  year: 2011
  ident: 10.1016/j.trim.2021.101461_bb0030
  article-title: Role of microRNA-155 in autoimmunity
  publication-title: Cytokine Growth Factor Rev.
  doi: 10.1016/j.cytogfr.2011.05.002
– volume: 32
  start-page: 2239
  issue: 12
  year: 2012
  ident: 10.1016/j.trim.2021.101461_bb0130
  article-title: MicroRNA-155 is required for Mycobacterium bovis BCG-mediated apoptosis of macrophages
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.06597-11
– volume: 118
  start-page: 5011
  issue: 18
  year: 2011
  ident: 10.1016/j.trim.2021.101461_bb0180
  article-title: Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORgammat in mice
  publication-title: Blood
  doi: 10.1182/blood-2011-03-340315
– volume: 373
  start-page: 1550
  issue: 9674
  year: 2009
  ident: 10.1016/j.trim.2021.101461_bb0005
  article-title: Graft-versus-host disease
  publication-title: Lancet (London, England)
  doi: 10.1016/S0140-6736(09)60237-3
– volume: 9
  start-page: 292
  issue: 5
  year: 2003
  ident: 10.1016/j.trim.2021.101461_bb0095
  article-title: Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses
  publication-title: Biology of blood and marrow transplantation
  doi: 10.1016/S1083-8791(03)00087-9
– volume: 377
  start-page: 2167
  issue: 22
  year: 2017
  ident: 10.1016/j.trim.2021.101461_bb0010
  article-title: Acute graft-versus-host disease - biologic process, prevention, and therapy
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1609337
– volume: 200
  start-page: 4170
  issue: 12
  year: 2018
  ident: 10.1016/j.trim.2021.101461_bb0100
  article-title: MicroRNA-155 modulates acute graft-versus-host disease by impacting T cell expansion, migration, and effector function
  publication-title: J. Immunol. (Baltimore, Md : 1950)
– volume: 118
  start-page: 4882
  issue: 18
  year: 2011
  ident: 10.1016/j.trim.2021.101461_bb0190
  article-title: Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas
  publication-title: Blood
  doi: 10.1182/blood-2011-02-334904
– volume: 173
  start-page: 5467
  issue: 9
  year: 2004
  ident: 10.1016/j.trim.2021.101461_bb0090
  article-title: Target antigens determine graft-versus-host disease phenotype
  publication-title: J. Immunol. (Baltimore, Md : 1950)
– volume: 173
  start-page: 1276
  issue: 2
  year: 2004
  ident: 10.1016/j.trim.2021.101461_bb0070
  article-title: Inhibition of farnesyltransferase prevents collagen-induced arthritis by down-regulation of inflammatory gene expression through suppression of p21(ras)-dependent NF-kappaB activation
  publication-title: J. Immunol. (Baltimore, Md : 1950)
– volume: 149
  start-page: 515
  issue: 3
  year: 2012
  ident: 10.1016/j.trim.2021.101461_bb0155
  article-title: Roles for microRNAs in conferring robustness to biological processes
  publication-title: Cell
  doi: 10.1016/j.cell.2012.04.005
– volume: 110
  start-page: 4588
  issue: 13
  year: 2007
  ident: 10.1016/j.trim.2021.101461_bb0200
  article-title: Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity
  publication-title: Blood
  doi: 10.1182/blood-2007-08-106005
– volume: 122
  start-page: 3365
  issue: 19
  year: 2013
  ident: 10.1016/j.trim.2021.101461_bb0035
  article-title: Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease
  publication-title: Blood
  doi: 10.1182/blood-2013-06-510586
– volume: 155
  start-page: 585
  issue: 2
  year: 1995
  ident: 10.1016/j.trim.2021.101461_bb0085
  article-title: Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease
  publication-title: J. Immunol. (Baltimore, Md : 1950)
– ident: 10.1016/j.trim.2021.101461_bb0040
  doi: 10.18632/oncotarget.15579
– volume: 113
  start-page: 1365
  issue: 6
  year: 2009
  ident: 10.1016/j.trim.2021.101461_bb0170
  article-title: In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations
  publication-title: Blood
  doi: 10.1182/blood-2008-06-162420
– volume: 14
  issue: 1
  year: 2018
  ident: 10.1016/j.trim.2021.101461_bb0125
  article-title: Mycobacterium tuberculosis-induced miR-155 subverts autophagy by targeting ATG3 in human dendritic cells
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1006790
– volume: 98
  start-page: 31
  issue: 1
  year: 2013
  ident: 10.1016/j.trim.2021.101461_bb0080
  article-title: Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells
  publication-title: Haematologica
  doi: 10.3324/haematol.2012.065789
– volume: 136
  start-page: 26
  issue: 1
  year: 2009
  ident: 10.1016/j.trim.2021.101461_bb0015
  article-title: MicroRNA control in the immune system: basic principles
  publication-title: Cell
  doi: 10.1016/j.cell.2008.12.027
– volume: 8
  issue: 370
  year: 2015
  ident: 10.1016/j.trim.2021.101461_bb0065
  article-title: T lymphocyte regulation by mevalonate metabolism
  publication-title: Sci. Signal.
  doi: 10.1126/scisignal.2005970
– volume: 126
  start-page: 103
  issue: 1
  year: 2015
  ident: 10.1016/j.trim.2021.101461_bb0045
  article-title: MicroRNA-155-deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation
  publication-title: Blood
  doi: 10.1182/blood-2014-12-617258
– volume: 14
  start-page: 24
  year: 2015
  ident: 10.1016/j.trim.2021.101461_bb0150
  article-title: SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-014-0284-y
– volume: 2
  start-page: 584
  issue: 11
  year: 2006
  ident: 10.1016/j.trim.2021.101461_bb0050
  article-title: Trafficking and signaling by fatty-acylated and prenylated proteins
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio834
– volume: 28
  start-page: 6773
  issue: 22
  year: 2008
  ident: 10.1016/j.trim.2021.101461_bb0140
  article-title: MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.00941-08
– volume: 27
  start-page: 1473
  issue: 13
  year: 2013
  ident: 10.1016/j.trim.2021.101461_bb0160
  article-title: MicroRNA-138 and SIRT1 form a mutual negative feedback loop to regulate mammalian axon regeneration
  publication-title: Genes Dev.
  doi: 10.1101/gad.209619.112
– volume: 6
  start-page: 541
  issue: 7
  year: 2007
  ident: 10.1016/j.trim.2021.101461_bb0055
  article-title: Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2221
– volume: 12
  start-page: 704
  issue: 6
  year: 2012
  ident: 10.1016/j.trim.2021.101461_bb0195
  article-title: Is there a future for prenyltransferase inhibitors in cancer therapy?
  publication-title: Curr. Opin. Pharmacol.
  doi: 10.1016/j.coph.2012.06.013
– volume: 197
  start-page: 829
  issue: 2
  year: 2008
  ident: 10.1016/j.trim.2021.101461_bb0210
  article-title: The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2007.07.031
– volume: 120
  start-page: 15
  issue: 1
  year: 2005
  ident: 10.1016/j.trim.2021.101461_bb0110
  article-title: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
  publication-title: Cell
  doi: 10.1016/j.cell.2004.12.035
– volume: 3
  issue: 3
  year: 2017
  ident: 10.1016/j.trim.2021.101461_bb0115
  article-title: miR-146 and miR-155: two key modulators of immune response and tumor development. Non-coding
  publication-title: RNA
– volume: 420
  start-page: 78
  issue: 6911
  year: 2002
  ident: 10.1016/j.trim.2021.101461_bb0205
  article-title: The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
  publication-title: Nature
  doi: 10.1038/nature01158
– volume: 65
  start-page: 241
  year: 1996
  ident: 10.1016/j.trim.2021.101461_bb0060
  article-title: Protein prenylation: molecular mechanisms and functional consequences
  publication-title: Annu. Rev. Biochem.
  doi: 10.1146/annurev.bi.65.070196.001325
SSID ssj0002597
Score 2.3044426
Snippet MicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte...
AbstractMicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 101461
SubjectTerms Acute Disease
Acute graft-versus-host disease
Allergy and Immunology
Animals
Feedback
Graft vs Host Disease
Mice
Mice, Inbred C57BL
microRNA-155
MicroRNAs - genetics
Polarization
Protein Prenylation
T lymphocyte
T-Lymphocytes, Regulatory
Title Inhibition of the miR-155 and protein prenylation feedback loop alleviated acute graft-versus-host disease through regulating the balance between T helper 17 and Treg cells
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0966327421001015
https://www.clinicalkey.es/playcontent/1-s2.0-S0966327421001015
https://dx.doi.org/10.1016/j.trim.2021.101461
https://www.ncbi.nlm.nih.gov/pubmed/34487810
https://www.proquest.com/docview/2570111131
Volume 69
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIhAXBOW1PCojcUNh48RxkmO1otoCrVDZSr1ZtmPTwJJdJVmkXvhF_EhmYmcRghaJk5VoLDuZ8Tzkb2YIeelKpzNVqShVZRpxlrtIVylEKabkxsZwoIbOc8cnYn7G355n5ztkNubCIKwy6H6v0wdtHd5Mw9-crut6-hGcb5HiTSMbCqVhojnnOUr56--_YB7g3g8p00AcIXVInPEYr76tMRs9YfiCC3aVcbrK-RyM0OFdcid4j_TAb_Ae2bHNHrnp-0le7pFbx-Gm_D75cdRc1HrAY9GVo-Dm0a_1aQR2naqmokN5hrqhWNHy0sPhqANDppX5Qper1Zpij5VvwDdbUWU2vaWfWuX6CFEcmy7C3BAaLndo6PVDW9_XHozhsJ5G1KSB0UPB6IJe2OXatpTlwx4WQE_x4qB7QM4O3yxm8yh0ZogMF0kflQ4cM65LmwgnMmWMKPMqi7UF26cql7AqA6-9KDjjNiltAXEJECW2cDbNqypPH5LdZtXYx4QyIxzTsYbISHPhlE7zUhgIzJXmWRIXE8JGlkgTypZj94ylHPFpnyWyUSIbpWfjhLzazln7oh3XUqcjp-WYjgoKVIJNuXZW_rdZtgs6oJNMdomM5R9yOiHZduZvov7PFV-MYihBByB_VGNXm05iJ0I0fSnQPPLyuf3uFOLvvGDxk_9c9Sm5jU8ewfOM7Pbtxj4HP6zX-8NB2yc3Dman7z_gePRufvITvTkzmg
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdGJz5eEAwY5dNIvKGocew4yeM0MbVs7QN00t4s27FZoEuqJkXa_8QfyTl2KiHYkHiK5NzJTs6-D_l3dwi9t4VVqSxlRGVBI0YyG6mSQpSiC6ZNDAeq7zw3X_DpOft0kV7soeMhF8bBKoPu9zq919ZhZBL-5mRdVZMv4Hxz6m4aSV8oLb2D9l11qnSE9o9mp9PFTiGDh99nTQN95BhC7oyHeXWbyiWkJ8QNME5usk83-Z-9HTp5hB4GBxIf-TU-RnumPkB3fUvJ6wN0bx4uy5-gn7P6slI9JAs3FoOnh6-qzxGYdizrEvcVGqoau6KW1x4Rhy3YMiX1d7xqmjV2bVZ-gOhMiaXedgZ_3UjbRQ7IsW0jlx6Cw_0ODu1-8Ma3tgd72M-nHHBSw9OjwfASX5rV2mwwyfo1LIEeu7uD9ik6P_m4PJ5GoTlDpBlPuqiw4JsxVZiEW55KrXmRlWmsDJg_WdqElCk47nnOCDNJYXIITYAoMbk1NCvLjD5Do7qpzXOEieaWqFhBcKQYt1LRrOAaYnOpWJrE-RiRQSRCh8rlroHGSgwQtW_CiVE4MQovxjH6sONZ-7odt1LTQdJiyEgFHSrArNzKlf2Ny7RBDbSCiDYRsfhjq45RuuP8bbf_c8Z3wzYUoAacfGRtmm0rXDNCZ_0o0Bz6_bn7bgoheJaT-MV_zvoW3Z8u52fibLY4fYkeuDce0PMKjbrN1rwGt6xTb8Kx-wWKKDS2
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inhibition+of+the+miR-155+and+protein+prenylation+feedback+loop+alleviated+acute+graft-versus-host+disease+through+regulating+the+balance+between+T+helper+17+and+Treg+cells&rft.jtitle=Transplant+immunology&rft.au=Wang%2C+Xiaoxiao&rft.au=Zhang%2C+Ran&rft.au=Huang%2C+Zhenli&rft.au=Zang%2C+Sibin&rft.date=2021-12-01&rft.issn=0966-3274&rft.volume=69&rft.spage=101461&rft.epage=101461&rft_id=info:doi/10.1016%2Fj.trim.2021.101461&rft.externalDBID=ECK1-s2.0-S0966327421001015&rft.externalDocID=1_s2_0_S0966327421001015
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09663274%2FS0966327421X00068%2Fcov150h.gif